IGC Pharma Inc.
Sector and Industry
Finance, Specialty Finance and Services
Performance (1Y)
4.84%
Market Cap
-
P/E Ratio (e)
0.00
Dividend Yield (e)
0.00 %
Earnings per Share (e)
-0.08 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Visa Inc. | 557.09 Bil. | 36.24 Bil. | 33.81 | +0.23 % | 0.00 | - |
| MasterCard Inc. Class A | 434.56 Bil. | 29.11 Bil. | 34.55 | +11.48 % | 0.00 | - |
| American Express Co | 216.09 Bil. | 71.34 Bil. | 24.06 | +2.62 % | 0.00 | - |
| Shopify Inc. Class A | 179.00 Bil. | 10.25 Bil. | 167.67 | -41.55 % | 0.00 | - |
| Capital One Financial Corporation | 129.00 Bil. | 61.23 Bil. | 60.15 | -57.66 % | 0.00 | - |
| Coinbase Global Inc. Class A | 51.57 Bil. | 6.37 Bil. | 50.85 | -53.12 % | 0.00 | - |
| PayPal Holdings Inc. | 45.73 Bil. | 29.55 Bil. | 10.80 | +20.99 % | 0.00 | - |
| Adyen NV | 43.36 Bil. | 2.67 Bil. | 40.78 | +14.85 % | 0.00 | - |
| CITIC Ltd. | 38.38 Bil. | 94.86 Bil. | 5.51 | -3.13 % | 0.00 | - |
| Block Inc. | 33.37 Bil. | 21.45 Bil. | 30.96 | -56.79 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 0.236 G | 0 Units |
| PRICE DETERMINATION TIME | 06/19/2026 / 09:56:33 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 0.238 | 0.234 |
| PREV. DAY'S PRICE | 0.238 | (06/18) |
| CHANGE DAY BEFORE | -0.00 | -0.84 % |
| 52 WEEK HIGH / LOW | 0.462 (07/10) | 0.198 (12/23) |
Key Figures (in EUR)
| 2027e | 2026e | 2025e | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | -0.07 | -0.08 | -0.04 | -0.09 | -0.20 |
| DIVIDENDS PER SHARE | - | - | - | 0.00 | 0.00 |
| DIVIDEND YIELD IN % | - | - | - | 0.00 % | 0.00 % |
| DIVIDEND GROWTH IN % | - | - | - | - | - |
| PRICE - EARNINGS RATIO | - | - | - | - | - |
| PRICE - BOOK RATIO | - | - | - | 3.64 | 3.64 |
| PRICE - SALES RATIO | - | - | - | 17.16 | 17.50 |
| PRICE - CASH FLOW RATIO | - | - | - | - | - |
Master Data
| WKN | A1T87A |
| ISIN | US45408X3089 |
| SYMBOL | - |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | India Globalization Capital |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Finance, Specialty Finance and Services |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -2.48 % | 0.00 % | 0.85 % | -13.87 % | -4.84 % | -7.81 % | -81.36 % | -0.84 % |
| HIGH | 0.25 | 0.31 | 0.31 | 0.31 | 0.46 | 0.67 | 3.63 | 0.31 |
| LOW | 0.23 | 0.23 | 0.21 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 |
Dividend
per share
India Globalization Capital does not deliver dividend information
Company profile
IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development. In addition to its drug development pipeline, IGC Pharma seeks to leverage artificial intelligence (AI) for Alzheimer's research. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.